Christoph Westphal
@drcwestphal
Followers
3K
Following
2K
Media
71
Statuses
3K
mdphd/hms vc/@longwoodfund founder/ceo/invest ALNY MNTA XLRN SIRT VSTM TCRX etc; ~20 approved drugs helping patients; building biotech at scale
Boston
Joined June 2010
Amazing - Alnylam market cap equals Regeneron market cap today
0
4
26
RT @CMichaelGibson: Happy Birthday to my friend and mentor Dr. Eugene Braunwald. Cleaning arteries together for nearly 40 yours now https:/….
0
30
0
Fun speaking at MIT today at the great ABI conference
0
0
1
RT @BiotechTVHQ: 𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬: @LongwoodFund's @drcwestphal on founding companies, venture investing, the current environment in biote….
0
1
0
RT @cngarabedian: Our next guest (Ep.19) on BioVenture VoiCes will be legendary @drcwestphal, Co-founder and General Partner of @LongwoodFu….
0
5
0
So great to be at MIT every year.
#MITCEO is hosted at @MIT @kochinstitute and brings together top researchers, biopharma leaders, and investors for 2 days of off-the-record discussion. View highlights from the meeting:
0
2
3
RT @JMaraganore: LEQVIO growing and approaching blockbuster status with @Novartis!. With AMVUTTRA, there will be two $B RNAi therapeutics….
0
4
0
A wonderful dinner w my dear old friend and lab benchmate @Alnylam head of R Kevin Fitzgerald. Originator of all 6 approved ALNY drugs.
0
2
24
RT @LongwoodLeaders: We had a terrific time hosting #biotech and #pharma CEOs and industry leaders at last week’s #MiamiCEO. We are gratefu….
0
2
0
RT @LongwoodLeaders: We are honored to be joined by world-class pharma and biotech leaders at the 3rd annual #MiamiCEO at The Ritz-Carlton….
0
3
0
Potentially a new class of medicines to help patients in need.
We’re pleased to announce the closing of our $41M Series A financing & the dosing of the first patient in our Phase 1 #CMML study. This funding supports the continued advancement of our CyTAC™ platform and pipeline, including new efforts in #immunology.
1
0
3
RT @LongwoodLeaders: We are honored that FDA CBER Director Peter Marks and @IAmBiotech John Crowley will join the conversation at #MiamiCEO….
0
2
0
Go ALNY!.
We are thrilled to share that the U.S. FDA has approved our supplemental New Drug Application (sNDA) for AMVUTTRA® (vutrisiran), making it available as a treatment option for a new group of patients. Read the press release: #RNAi #RNAiTherapeutics.
0
0
6
RT @LongwoodLeaders: Co-hosted with @MIT President Sally Kornbluth, Phil Sharp (co-founder Biogen/Alnylam), Bob Langer (co-founder Moderna)….
0
1
0
RT @LongwoodLeaders: It has been our honor to host amazing female leaders across the life sciences, academia & government at #LongwoodHealt….
0
1
0
We had over 150 great biopharma leaders at our longwood office for cocktails and to celebrate the Celtics (Ray from novo is a warriors fan boo :) )
0
2
8
RT @LongwoodLeaders: We were honored to host cross industry stakeholders at #SanFranciso immediately prior to #JPM. See the 3 minute event….
longwoodhealthcareleaders.com
0
2
0